Hematological and infectious complications with CD38 antigen targeting monoclonal antibody-based therapies in multiple myeloma: A meta-analysis of randomized control trials.

Autor: Yarlagadda N; University of Arkansas for Medical Sciences, Little Rock, AR, United States., Gundarlapalli S; University of Arkansas for Medical Sciences, Little Rock, AR, United States., Sharma S; Unversity of Nebraska Medical Center, Omaha, NE, United States., Suelzer E; Medical College of Wisconsin, Milwaukee, WI, United States., Abid MB; Medical College of Wisconsin, Milwaukee, WI, United States., Abdallah AO; University of Kansas Medical Center, United States., Schinke C; University of Arkansas for Medical Sciences, Little Rock, AR, United States., Atrash S; Atrium Health Levine Cancer Institute, NC, United States., Mohan M; Medical College of Wisconsin, Milwaukee, WI, United States. Electronic address: memohan@mcw.edu.
Jazyk: angličtina
Zdroj: Leukemia research [Leuk Res] 2021 Nov; Vol. 110, pp. 106714. Date of Electronic Publication: 2021 Sep 25.
DOI: 10.1016/j.leukres.2021.106714
Databáze: MEDLINE
Externí odkaz: